English
Insider transactions
EDGARY-mAbs Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
This issuer has insider filings in the store, but no transaction in this window or code group.
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Beryl Capital Management LLC Common Stock | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-25-000695 Dispute this row |
| Beryl Capital Management LP Common Stock | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-25-000695 Dispute this row |
| Beryl Capital Partners II LP Common Stock | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-25-000695 Dispute this row |
| David A. Witkin Common Stock | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-25-000695 Dispute this row |
| HBM Healthcare Investments (Cayman) Ltd. Common Stock, $0.0001 par value | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 7 | Open filing 0001104659-25-112490 Dispute this row |
| Caligan Partners LP Common stock, par value $0.0001 per share | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-25-004973 Dispute this row |
| David Johnson Common stock, par value $0.0001 per share | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-25-004973 Dispute this row |
| Paradigm BioCapital Advisors LP Common Stock, $0.0001 par value per share | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-112618 Dispute this row |
| Paradigm BioCapital Advisors GP LLC Common Stock, $0.0001 par value per share | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-112618 Dispute this row |
| Senai Asefaw, M.D. Common Stock, $0.0001 par value per share | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-112618 Dispute this row |
| Paradigm BioCapital International Fund Ltd. Common Stock, $0.0001 par value per share | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-112618 Dispute this row |
| Glazer Capital, LLC Common Stock, $0.0001 par value | 0.00 | 0.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001076809-25-000139 Dispute this row |
| Paul J. Glazer Common Stock, $0.0001 par value | 0.00 | 0.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001076809-25-000139 Dispute this row |
| ACORN BIOVENTURES, L.P. Common stock, par value $0.0001 per share | 2.6 | 1,175,686.00 | 08/19/2025 Filed 2025-08-20 | SCHEDULE 13G/AAmendment 3 | Open filing 0001636587-25-000047 Dispute this row |
| ACORN CAPITAL ADVISORS GP, LLC Common stock, par value $0.0001 per share | 2.6 | 1,175,686.00 | 08/19/2025 Filed 2025-08-20 | SCHEDULE 13G/AAmendment 3 | Open filing 0001636587-25-000047 Dispute this row |
| ACORN BIOVENTURES 2, L.P. Common stock, par value $0.0001 per share | 3.6 | 1,620,611.00 | 08/19/2025 Filed 2025-08-20 | SCHEDULE 13G/AAmendment 3 | Open filing 0001636587-25-000047 Dispute this row |
| Acorn Capital Advisors GP 2, LLC Common stock, par value $0.0001 per share | 3.6 | 1,620,611.00 | 08/19/2025 Filed 2025-08-20 | SCHEDULE 13G/AAmendment 3 | Open filing 0001636587-25-000047 Dispute this row |
| Anders Hove Common stock, par value $0.0001 per share | 6.2 | 2,796,297.00 | 08/19/2025 Filed 2025-08-20 | SCHEDULE 13G/AAmendment 3 | Open filing 0001636587-25-000047 Dispute this row |
| ACORN BIOVENTURES, L.P. Common stock, par value $0.0001 per share | 3.0 | 1,301,686.00 | 08/14/2025 Filed 2025-08-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001636587-25-000045 Dispute this row |
| ACORN CAPITAL ADVISORS GP, LLC Common stock, par value $0.0001 per share | 3.0 | 1,301,686.00 | 08/14/2025 Filed 2025-08-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001636587-25-000045 Dispute this row |
| ACORN BIOVENTURES 2, L.P. Common stock, par value $0.0001 per share | 4.0 | 1,794,611.00 | 08/14/2025 Filed 2025-08-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001636587-25-000045 Dispute this row |
| Acorn Capital Advisors GP 2, LLC Common stock, par value $0.0001 per share | 4.0 | 1,794,611.00 | 08/14/2025 Filed 2025-08-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001636587-25-000045 Dispute this row |
| Anders Hove Common stock, par value $0.0001 per share | 7.0 | 3,096,297.00 | 08/14/2025 Filed 2025-08-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001636587-25-000045 Dispute this row |
| Glazer Capital, LLC Common Stock, $0.0001 par value | 5.84 | 2,654,700.00 | 08/08/2025 Filed 2025-08-15 | SCHEDULE 13G | Open filing 0001076809-25-000098 Dispute this row |
| Paul J. Glazer Common Stock, $0.0001 par value | 5.84 | 2,654,700.00 | 08/08/2025 Filed 2025-08-15 | SCHEDULE 13G | Open filing 0001076809-25-000098 Dispute this row |
| Beryl Capital Management LLC Common Stock | 9.0 | 4,087,091.00 | 08/05/2025 Filed 2025-08-12 | SCHEDULE 13G | Open filing 0000935836-25-000492 Dispute this row |
| Beryl Capital Management LP Common Stock | 9.0 | 4,087,091.00 | 08/05/2025 Filed 2025-08-12 | SCHEDULE 13G | Open filing 0000935836-25-000492 Dispute this row |
| Beryl Capital Partners II LP Common Stock | 6.8 | 3,095,833.00 | 08/05/2025 Filed 2025-08-12 | SCHEDULE 13G | Open filing 0000935836-25-000492 Dispute this row |
| David A. Witkin Common Stock | 9.0 | 4,087,091.00 | 08/05/2025 Filed 2025-08-12 | SCHEDULE 13G | Open filing 0000935836-25-000492 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,592,621 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 218,850 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,467 |
Filings made before the SEC required XML are listed, not extracted.